Compound ID | 3026
Class: Antimicrobial peptide
| Details of activity: | Active against Mycobacterium phlei and Mycobacterium smegmatis |
| Description: | Natural product from Streptomyces sp.; a lasso peptide; inferior to kanamycin against tuberculosis infection in mice |
| Year first mentioned: | 1958 |
| Highest developmental phase: | Preclinical (1967) |
| Development status: | Inactive |